Pinz Capital Management, LP Gilead Sciences, Inc. Transaction History

Pinz Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $101,552 - $110,959	-1,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $330,000 - $376,529	-5,500 Reduced 77.46%	1,600 $103,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $402,215 - $458,305	7,100 New	7,100 $414,000
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $2.19 Million - $2.81 Million	-35,000 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $2.16 Million - $2.37 Million	35,000 New	35,000 $2.27 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Pinz Capital Management, LP with notifications on news.